Advanced search
Publication Cover
Expert Review of Vaccines Volume 12, 2013 - Issue 6
Submit an article Journal homepage
262
Views
29
CrossRef citations to date
0
Altmetric
Review

Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases

Vijayendra Dasari Centre for Immunotherapy and Vaccine Development, Department of Immunology, Queensland Institute of Medical Research, 300 Herston Road, Brisbane, QLD 4006, Australia
,
Corey Smith Centre for Immunotherapy and Vaccine Development, Department of Immunology, Queensland Institute of Medical Research, 300 Herston Road, Brisbane, QLD 4006, Australia
&
Rajiv Khanna Centre for Immunotherapy and Vaccine Development, Department of Immunology, Queensland Institute of Medical Research, 300 Herston Road, Brisbane, QLD 4006, Australia. [email protected]
Pages 661-676 | Published online: 09 Jan 2014

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Cosmina Hogea, Ilse Dieussaert, Thierry Van Effelterre, Adrienne Guignard & Johann Mols. (2015) A dynamic transmission model with age-dependent infectiousness and reactivation for cytomegalovirus in the United States: Potential impact of vaccination strategies on congenital infection. Human Vaccines & Immunotherapeutics 11:7, pages 1788-1802.
Read now
Vijayendra Dasari, Corey Smith, Andrea Schuessler, Jie Zhong & Rajiv Khanna. (2014) Induction of innate immune signatures following polyepitope protein-glycoprotein B-TLR4&9 agonist immunization generates multifunctional CMV-specific cellular and humoral immunity. Human Vaccines & Immunotherapeutics 10:4, pages 1064-1077.
Read now
Chris A Benedict. (2013) A CMV vaccine: TREATing despite the TRICKs. Expert Review of Vaccines 12:11, pages 1235-1237.
Read now

Articles from other publishers (26)

Mark R. Schleiss. 2023. Plotkin's Vaccines. Plotkin's Vaccines 258 274.e9 .
Vijayendra Dasari, Kirrilee Beckett, Shane Horsefield, George Ambalathingal & Rajiv Khanna. (2022) A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice. PLOS Pathogens 18:6, pages e1010403.
Crossref
Yan Zheng, Xiaojian Qiu, Ting Wang & Jie Zhang. (2021) The Diagnostic Value of Metagenomic Next–Generation Sequencing in Lower Respiratory Tract Infection. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Eliza Gordon‐Lipkin, Alexander Hoon & Carlos A Pardo. (2020) Prenatal cytomegalovirus, rubella, and Zika virus infections associated with developmental disabilities: past, present, and future. Developmental Medicine & Child Neurology 63:2, pages 135-143.
Crossref
J. Reina. (2020) Current status of vaccines against congenital cytomegalovirus infection: The paradox of previous immunity. Vacunas (English Edition) 21:2, pages 111-120.
Crossref
J. Reina. (2020) Estado actual de las vacunas frente a la infección congénita por citomegalovirus: la paradoja de la inmunidad previa. Vacunas 21:2, pages 111-120.
Crossref
Gaelle Picarda, Raima Ghosh, Bryan McDonald, Shilpi Verma, Nicolas Thiault, Rachid El Morabiti, Thomas S. Griffith & Chris A. Benedict. (2019) Cytomegalovirus Evades TRAIL-Mediated Innate Lymphoid Cell 1 Defenses. Journal of Virology 93:16.
Crossref
Sevan N. AlwanHaidar A. ShamranAvan H. GhaibHaider S. KadhimQasim S. Al-MayahAtheer J. AL-SaffarAli H. BayatiHala S. ArifJianmin Fu & Brian L. Wickes. (2019) Genotyping of Cytomegalovirus from Symptomatic Infected Neonates in Iraq. The American Journal of Tropical Medicine and Hygiene 100:4, pages 957-963.
Crossref
Mark R. Schleiss & Stanley A. Plotkin. 2018. Plotkin's Vaccines. Plotkin's Vaccines 228 240.e6 .
. (2017) Humanes Cytomegalievirus (HCMV). Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 61:1, pages 116-128.
Crossref
K.M. Edwards & C.B. Creech. 2017. Human Vaccines. Human Vaccines 163 185 .
Bodo Plachter. (2016) Prospects of a vaccine for the prevention of congenital cytomegalovirus disease. Medical Microbiology and Immunology 205:6, pages 537-547.
Crossref
Kirsten Schneider-Ohrum, Corinne Cayatte, Yi Liu, Zhaoti Wang, Alivelu Irrinki, Floro Cataniag, Nga Nguyen, Stacie Lambert, Hui Liu, Shahin Aslam, Greg Duke, Michael P. McCarthy & Louise McCormick. (2016) Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers. Journal of Virology 90:22, pages 10133-10144.
Crossref
K. M. Anderholm, C. J. Bierle & M. R. Schleiss. (2016) Cytomegalovirus Vaccines: Current Status and Future Prospects. Drugs 76:17, pages 1625-1645.
Crossref
Daniel C. Chambers. (2016) Controlling Cytomegalovirus in the Age of Personalized Medicine. American Journal of Respiratory and Critical Care Medicine 193:1, pages 10-11.
Crossref
Alexia Willame, Geraldine Blanchard-Rohner, Christophe Combescure, Olivier Irion, Klara Posfay-Barbe & Begoña Martinez de Tejada. (2015) Awareness of Cytomegalovirus Infection among Pregnant Women in Geneva, Switzerland: A Cross-sectional Study. International Journal of Environmental Research and Public Health 12:12, pages 15285-15297.
Crossref
Flavia Chiuppesi, Felix Wussow, Erica Johnson, Chao Bian, Meng Zhuo, Augustine Rajakumar, Peter A. Barry, William J. Britt, Rana Chakraborty & Don J. Diamond. (2015) Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection. Journal of Virology 89:23, pages 11884-11898.
Crossref
Claudio Ciferri, Sumana Chandramouli, Alexander Leitner, Danilo Donnarumma, Michael A. Cianfrocco, Rachel Gerrein, Kristian Friedrich, Yukti Aggarwal, Giuseppe Palladino, Ruedi Aebersold, Nathalie Norais, Ethan C. Settembre & Andrea Carfi. (2015) Antigenic Characterization of the HCMV gH/gL/gO and Pentamer Cell Entry Complexes Reveals Binding Sites for Potently Neutralizing Human Antibodies. PLOS Pathogens 11:10, pages e1005230.
Crossref
Sungchul Kim, Daekwan Seo, Dongwoo Kim, Yujin Hong, Hyeshik Chang, Daehyun Baek, V. Narry Kim, Sungwook Lee & Kwangseog Ahn. (2015) Temporal Landscape of MicroRNA-Mediated Host-Virus Crosstalk during Productive Human Cytomegalovirus Infection. Cell Host & Microbe 17:6, pages 838-851.
Crossref
Richard L. Hodinka. 2015. Manual of Clinical Microbiology . Manual of Clinical Microbiology 1718 1737 .
Huadong Wang, Chaoyang Huang, Jinrong Dong, Yanfeng Yao, Zhenyuan Xie, Xueying Liu, Wenjie Zhang, Fang Fang & Ze Chen. (2015) Complete Protection of Mice against Lethal Murine Cytomegalovirus Challenge by Immunization with DNA Vaccines Encoding Envelope Glycoprotein Complex III Antigens gH, gL and gO. PLOS ONE 10:3, pages e0119964.
Crossref
Irena Slavuljica, Daria Kveštak, Peter Csaba Huszthy, Kate Kosmac, William J Britt & Stipan Jonjić. (2014) Immunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus model. Cellular & Molecular Immunology 12:2, pages 180-191.
Crossref
A. Louise McCormick & Edward S. Mocarski. (2014) The immunological underpinnings of vaccinations to prevent cytomegalovirus disease. Cellular & Molecular Immunology 12:2, pages 170-179.
Crossref
Vijayendra Dasari & Rajiv Khanna. (2015) Vaccination for cytomegalovirus: when, where and how. Microbiology Australia 36:4, pages 175.
Crossref
Luis A. Brito, Sushma Kommareddy, Domenico Maione, Yasushi Uematsu, Cinzia Giovani, Francesco Berlanda Scorza, Gillis R. Otten, Dong Yu, Christian W. Mandl, Peter W. Mason, Philip R. Dormitzer, Jeffrey B. Ulmer & Andrew J. Geall. 2015. Nonviral Vectors for Gene Therapy - Physical Methods and Medical Translation. Nonviral Vectors for Gene Therapy - Physical Methods and Medical Translation 179 233 .
Jasmine Riviere Marcelin. (2014) Cytomegalovirus infection in liver transplant recipients: Updates on clinical management. World Journal of Gastroenterology 20:31, pages 10658.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.